Global clinical nutrition market will reach $107.65 billion by 2032, growing by 8.2% annually over 2022-2032. The growth is driven by the increasing incidence of malnutrition, the rising prevalence of chronic diseases, the growing awareness pertaining to health and fitness among people, and the higher number of premature births.Highlighted with 120 tables and 110 figures, … Read more
North America clinical nutrition market is projected to grow by 7.6% annually in the forecast period and reach $27.64 billion by 2032. The growth is driven by the increasing incidence of malnutrition, the rising prevalence of chronic diseases, the growing awareness pertaining to health and fitness among people, and the higher number of premature births.Highlighted … Read more
Europe clinical nutrition market was valued at $10.3 billion in 2022 and will grow by 7.8% annually over 2022-2032. The growth is driven by the increasing incidence of malnutrition, the rising prevalence of chronic diseases, the growing awareness pertaining to health and fitness among people, and the higher number of premature births.Highlighted with 71 tables … Read more
Asia Pacific clinical nutrition market will grow by 9.2% annually with a total addressable market cap of $328.51 billion over 2023-2032. The growth is driven by the increasing incidence of malnutrition, the rising prevalence of chronic diseases, the growing awareness pertaining to health and fitness among people, and the higher number of premature births.Highlighted with … Read more
Global pharmaceutical manufacturing industry market will reach $25.77 billion by 2032, growing by 9.3% annually over 2022-2032. The growth is driven by the increased drug approvals, increasing prevalence of chronic ailments, growing geriatric population, high R&D investment in pharmaceutical industry, increasing per capita healthcare expenditure, and technological advancements in manufacturing processes.Highlighted with 142 tables and … Read more
North America pharmaceutical manufacturing industry market is projected to grow by 8.3% annually in the forecast period and reach $9.08 million by 2032. The growth is driven by the increased drug approvals, increasing prevalence of chronic ailments, growing geriatric population, high R&D investment in pharmaceutical industry, increasing per capita healthcare expenditure, and technological advancements in … Read more
Europe pharmaceutical manufacturing industry market was valued at $2.84 billion in 2022 and will grow by 8.6% annually over 2022-2032. The growth is driven by the increased drug approvals, increasing prevalence of chronic ailments, growing geriatric population, high R&D investment in pharmaceutical industry, increasing per capita healthcare expenditure, and technological advancements in manufacturing processes.Highlighted with … Read more
North America connected healthcare device market is projected to grow by 18.9% annually in the forecast period and reach $106.9 billion by 2033. The growth is driven by the emergence of telehealth and telemedicine services, benefits such as reliability and effective patient monitoring, the penetration of mobile and internet technology, government initiatives, growing spending on … Read more
Europe connected healthcare device market was valued at $16 billion in 2023 and will grow by 19.2% annually over 2023-2033. The growth is driven by the emergence of telehealth and telemedicine services, benefits such as reliability and effective patient monitoring, the penetration of mobile and internet technology, government initiatives, growing spending on R&D activities, and … Read more
Asia Pacific connected healthcare device market will grow by 21.1% annually with a total addressable market cap of $495.3 billion over 2024-2033. The growth is driven by the emergence of telehealth and telemedicine services, benefits such as reliability and effective patient monitoring, the penetration of mobile and internet technology, government initiatives, growing spending on R&D … Read more